A 52-kD protein is a novel component of the SS-A/Ro antigenic particle by unknown
A 52-kD PROTEIN IS A NOVEL COMPONENT OF THE
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The SS-A/Ro autoantigen is a small intracellular RNA-protein complex that
is the target of autoantibodies present in the sera of many patients with SLE
and Sjogren's syndrome (SS)' (1, 2). The protein component(s) ofSS-A/Ro have
been variously described as polypeptides with molecular masses ranging from 50
to 150 kD (Table I). In human cells SS-A/Ro is associated with at least four
RNAs (Y RNAs), ranging from 80 to 112 bases (3). The antigenic reactivity of
SS-A/Ro is apparently independent of RNA since the precipitin activity of SS-
A/Ro is not affected by RNAse and since autoantibodies bind the protein after
separation from the RNA (4). Immunological properties of the SS-A/Ro antigen
extracted from human and other mammalian tissues were initially reported by
Clark et al. (5), Mattioli and Reichlin (6), and Alspaugh and Tan (7). Recently,
it has been the subject of more definitive biochemical evaluation using Western
blot and ELISA techniques (8-10).
Despite our considerable knowledge of these particles, the number and iden-
tity of the proteins associated with the SS-A/Ro particle have not been well
defined. Wolin and Steitz (3) reported that the major antigenic protein present
in human HeLa cells was a polypeptide of 60 kD. Elkon and Culhane (8)
reported that antigenic determinants were identified on polypeptides of 50 kD
and/or 57 kD. They suggested that the 50-kD species might be a degradation
product of the 57-kD protein as has been shown for the 43-kD and 48-kD SS-
B/La polypeptides (9, 11).
Recently we have examined sera from patients with Sjogren's syndrome for
their profile ofautoantibodies using several different immunochemical methods.
We have detected a 52-kD protein in addition to the 60-kD polypeptide that
appears to be a major component of the SS-A/Ro antigenic system. The present
study was designed to characterize this protein and its relationship with the 60-
kD SS-A/Ro antigen.
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TABLE I
Reported Molecular Massfor SS-AlRo
Materials and Methods
1561
Patients' Sera.
￿
We studied sera from 61 patients with Sjogren's syndrome who were
evaluated in the Rheumatology Division at Scripps Clinic and Research Foundation. Cri-
teria for the diagnosis of Sjogren's syndrome were as previously described (12).
Cell Extracts and Labeling (Preparation of Antigens).
￿
HeLa (American Type Culture
Collection, Rockville, MD), SAL-1 (human salivary gland tumor cell line) obtained from
Dr. R. I. Fox (Scripps Clinic) were grown in monolayer cultures with DME containing
10% calf serum at 37°C in a 10% C02 incubator. The Raji cell line was obtained from
Dr. A. N. Theofilopoulos (Scripps Clinic).
Cultures were supplemented with 2.5 p,g/ml gentamicin sulfate and used at subcon-
fluent densities. Cells were washed twice with PBS, and extracted in buffer A (150 mM
NaCl, 10 mM Tris-Hcl, pH 7.2, 0.5% NP-40) or in Empigen BB (Albright and Wilson,
Old Tappan, NJ) and freed of cell nuclei by centrifugation at 12,000 g for 15 min. Wil-
2 extract was prepared by sonication according to a previously described method (13).
Cells were labeled for 16 h with
[32p]orthophosphate (NEN Research Products, Boston,
MA), or [BSS]methionine (Research Products International Corp., Mount Prospect, IL)
both at 100 mCi/ml in phosphate- or methionine-free media (Flow Laboratories Inc.,
McLean, VA), respectively, each supplemented with 2% calf serum. The cells were then
harvested as described above.
Gel Double Diffusion (Ouchterlony).
￿
Antibodies to the SS-A/Ro antigen were detected
by using double immunodiffusion in 0 .5% agarose. Precipitin lines were formed after
interaction of Wil-2 extract (protein concentration 20 mg/ml) with 1 :1 and 1 :30 dilu-
tions of sera and read after 48 h (14).
Polyacrylamide Gel Electrophoresis (PAGE). SDS-PAGE was performed following the
method described by Laemmli (15), in 15% acrylamide gel slabs. The following protein
standards were used to determine molecular weights: phosphorylase B, 92,500; BSA,
66,200 ; OVA, 45,000; carbonic anhydrase, 31,000 ; soybean trypsin inhibitor, 21,500 ;
and lysozyme, 14,400.
Western Blotting.
￿
Electrophoretic blotting was performed using the method of Tow-
bin et al. (16) with some modifications. Briefly, proteins were separated by SDS-PAGE
and were electrotransferred to a nitrocellulose sheet for 3 h at constant voltage of 60 V.
The nitrocellulose sheets were then incubated for 1 h in PBS with 0.5% Tween 20 (PBS-
T) and 3% nonfat milk to block nonspecific binding sites. Then the nitrocellulose strips
or sheets were incubated with a 1 :100 dilution of sera, washed for 1 h in PBS-T.
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protein A (ICN Biochemicals, Irvine, CA) was used to detect bound human Ig.
Affinity Purification ofAutoantibodies.
￿
Anti-SS-A/Ro and anti-SS-B/La antibodies were
affinity purified according to previously described methods (17, 18) . Briefly, HeLa cell
extracts (protein concentration 25 mg/ml) were electrophoretically separated on 30-cm
lengths of 15% polyacrylamide gels and transferrred to nitrocellulose paper as described
Author Year Mol mass Method Reference
kD
Clark et al. 1969 100-150 Gel filtration 5
Francoeur et al. 1982 90,94 Immunoprecipitation 26
Venables et al. 1983 55 SDS-PAGE staining 29
Lieu et al. 1984 60 Immunoblotting 30
Wolin et al. 1984 60 Immunoprecipitation 3
Elkon et al. 1984 50,57 Immunoblotting 8,9
Deng et al. 1985 60 Immunoblotting 31
Herrera-Esparza et al. 1986 58 Immunoblotting 32
Bachmann et al. 1986 90,94 Immunoblotting 251562
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above. To identify the proteins, the outer lanes of the nitrocellulose sheet were blotted
and detected by positive anti-SS-A/SS-B sera using '251-protein A. The protein bands
were cut out as horizontal strips from the remaining nitrocellulose, cut into smaller
pieces (-1 mm2) and washed in PBS-T and 3% nonfat milk for 1 h. Then they were
incubated for 1 .5 hours with a human anti-SS-A/SS-B autoimmune serum diluted 1 :50
in PBS-T and 3% nonfat milk, followed by washing six times with PBS-T, twice in PBS,
and once in 0 .25 M KCl in PBS for 2 min. For elution of specifically bound antibodies,
the nitrocellulose was incubated with 0.2 M glycine-HCI, pH 2 .7, and 1 mg/ml BSA for
2 min. The eluate was neutralized immediately with 1 M Tris-HCl, pH 8.7, dialyzed
against PBS overnight and concentrated by dialysis against PEG 20,000 (Kodak).
Partial Proteolysis of SS-A/SS-B Antigens.
￿
The procedure followed the method of
Cleveland et. al. (19) with modifications. In the first dimension, 190AI of HeLa cell
extract (25 mg/ml) in Laemmli sample buffer was loaded onto a 1-mm thick 15% poly-
acrylamide gel . After electrophoresis, the gel was cut into 10 slices of 0.8 cm each and
soaked in Laemmli sample buffer with 0.1% SDS for 15 min. Then the slices were loaded
onto 1 .5-mm thick 15% polyacrylamide gel. 300 Al of a protease solution (Staphylococcus
aureus V8 protease; Sigma Chemical Co., St. Louis, MO) at different concentrations (1-
50 Ag/ml) in Laemmli sample buffer with 0 .1% SDS was layered on top of the gel slices.
During the electrophoresis, proteolysis was allowed to occur in the stacking gel.
Immunoprecipitation and SDS-PAGE Analysis of Labeled Cellular Antigens.
￿
Protein A-
Sepharose-facilitated immunoprecipitation of labeled cellular antigen by antisera or
affinity-purified antibodies was performed as described (11) . Typically, 10 Al of antisera
were added to 500 Al buffer B (50 mM Tris-HCI, pH 7.4, 150 mM NaCl, 5 mM EDTA,
0 .5% NP-40, 0.5% sodium deoxycholate, 0.1% SDS) and 100 A1 of 10% (wt/vol) protein
A-Sepharose beads in buffer B. After mixing for 1 h at 4°C the beads were washed three
times in buffer B. Then 25 A.1 of labeled extract, 20 A1 BSA (50 mg/ml), and 500 141 buffer
B were added and mixed for 1 h more at 4°C. The precipitates were washed five times
with 1 ml buffer B. The protein was eluted by boiling in Laemmli sample buffer and
analyzed by SDS-PAGE (15). For RNA analysis, precipitates were extracted with phenol
and RNAs were precipitated with ethanol and electrophoresed in 7 M urea, 8% poly-
acrylamide gels.
Immunofuorescence Studies.
￿
Prefixed HEp-2 cell slides were obtained from Bion (Park
Ridge, IL). Additional cell lines were grown in Lab-Tek tissue culture chambers (Miles
Laboratories, Naperville, IL) following manufacturer's instructions and fixed in a mix-
ture of acetone and methanol 1 :3 at -20°C for 2 min followed by air drying. Human
monospecific sera as well as affinity-purified antibodies were tested. Antibodies were
detected using fluorescein-labeled affinity-purified goat anti-human Ig A+G+M
(H+L) antibodies (Calbiochem-Behring Corp., La Jolla, CA).
Results
61 patients with Sjogren's syndrome were analyzed for anti-SS-A/Ro auto-
antibodies by Ouchterlony immunodiffusion using Wil-2 cell extracts as the anti-
gen source. 42 patients (69%) possessed anti-SS-A/Ro antibodies as demon-
strated by the presence of immunoprecipitin lines displaying identity to the
anti-SS-A/Ro prototype and 27 (44%) had anti-SS-B/La activity. The fine spec-
ificities of the SS-A/Ro antigen-antibody system were further resolved into four
classes using immunoblot analysis. 21 (50%) of the 42 sera reacted with two pro-
teins of 60 and 52 kD, 13 sera (31%) reacted primarily with the 52-kD and not
the 60-kD protein, two sera detected only the 60-kD antigen, and six sera were
nonreactive with either protein. Noteworthy is the fact that the two sera reactive
with the 60-kD and not with the 52-kD protein were from SLE patients and
contained anti-Sm and other antibodies as well . Representative immunoblots of
each of the three reactive groups of sera are shown in Fig. 1 where solubleBEN-CHETRIT ET AL.
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FIGURE 1 . Immunoblotting
analysis of reactivities of rep-
resentative sera from patients
with SS, using HeLa cell
extract . Lanes 1-4 demon-
strate the presence of anti-
bodies to 60-, 52-, 48-, and
43-kD bands . Lanes 5 and 6
show antibodies to the 60-kD
protein and not to the 52-kD
antigen . Lanes 7-10 show
antibodies to the 52-kD band
but not the 60-kD polypep-
tide . Lane 11 represents nor-
mal serum and lane 12 is a
monospecific anti-SS-B pro-
totype serum . The 43-kD
band is adegradation product
of the 48-kD SS-B protein .
Note that sera 5 and 6
derived from SLE patients
also contained other anti-
bodies . Serum 10 served as a
monospecific anti-52-kD
antiserum in subsequent
studies .
HeLa cell proteins were used as antigen . Identical immunoblot results were
obtained with Raji and Wil-2 cell extracts .
These data indicate a substantial degree of heterogeneity in the autoimmune
response against SS-A/Ro among individual patients . Further, the existence of
sera with specificity directed against either the 52- or the 60-kD antigens sug-
gested that the antibodies present in these sera might be recognizing distinct
epitopes on these proteins .
The relationship between SS-A/Ro and SS-B/La is complicated by the fact
that in most sera with anti-SS-B/La specificity there are also anti-SS-A/Ro anti-
bodies . It was previously reported that SS-A/Ro and SS-B/La might share some
common antigenic proteolytic degradation fragments (9) . In view of the present
identification of an apparently new 52-kD component of the SS-A/Ro system it
was appropriate to reexamine the antigenic relationships among the 52-, 60-,
and 48-kD proteins .
The first method used partial S.a.V8 protease digestion of HeLa cell extract.
Fig. 2 shows that the 60-kD protein has a 44-kD degradation product, the 52-
FIGURE 2 .
￿
Partial proteolysis
of HeLa cell extract by S.a .
V8 protease. (A) Commassie
blue staining of two dimen-
sional 15% polyacrylamide gel
of cell extract digested with
10 pg/ml protease . (B) Immu-
noreactive fragments of the
different proteins 60 kD, 52
kD, and SS-B (48 kD), as
detected by antibody and'Y5I
labeled protein A . None of the degradation products of SS-A or SS-B have the same molecular
weights . Note that the scales for the molecular weight markers in the two panels are different .1564
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kD has a 38-kD fragment and the 48-kD SS-B/La has the 43-kD as well as X/X'
and Y fragments (9). No common antigenic polypeptide fragments were
observed among the 52-, 60-kD and SS-B/La 48-kD proteins even when a variety
of protease concentrations were used (data not shown) .
From Fig . 1 it is clear that some sera reacted only with the 52-kD and others
only with the 60-kD polypeptide. However, we wanted to determine whether in
sera reactive with both proteins the antibodies were crossreactive . Fig. 3 shows
the reactivity of high titer sera that contained antibodies to 60-kD, 52-kD, and
SS-B/La proteins (lanes 1-2) . Affinity-purified antibodies from either the 60- or
the 52-kD band reacted specifically with 60- and 52-kD antigens respectively
(lanes 3-4) . Affinity-purified antibodies from the 48-kD SS-B/La protein
reacted with the 48-kD band and its degradation product of 43 kD (lane 5) .
These data indicate that the above antigens contained different and unique
epitopes .
The lack of crossreactivity among affinity-purified antibodies demonstrated
that the two antigens, 52 and 60 kD, were immunologically distinct . However,
both proteins were simultaneously targeted for autoimmune response in 50% of
the Sjogren's syndrome patients who were positive for SS-A antibody by immu-
nodiffusion analysis . It was therefore of interest to examine the composition of
antigens in the precipitin lines observed in immunodiffusion plates. SS-A pre-
cipitin lines were excised from Ouchterlony immunodiffusion plates, washed
thoroughly, separated on SDS-PAGE and transferred to nitrocellulose . Analysis
performed on precipitins isolated from three different sera using Western blot-
ting demonstrated the presence of immunoreactive 52- and 60-kD proteins in
these precipitin lines (data not shown) . On the other hand, the SS-B precipitin
lines analyzed in a similar fashion showed only the 48-kD protein and its 43-kD
degradation product . The high frequency of combined anti-52-kD and anti-60-
kD antibodies in anti-SS-A/Ro sera as well as the single precipitin line of anti-
SS-A/Ro produced by both antibodies in Ouchterlony immunodiffusion led us
FIGURE 3.
￿
Immunoblotting analysis of the reactivities of whole sera and
affinity-purified antibodies to 60-kD, 52-kD, and SS-B proteins, using
HeLa cell extract . Lane 1 represents a serum from a patient with SS,
containing antibodies to 60-kD, 52-kD proteins as well as to the 48-kD
and 43-kD components of SS-B . Lane 2 shows reactivity of serum positive
mainly for anti-60-kD and 52-kD antibodies . Lanes 3-5 demonstrate the
affinity-purified antibodies to each component, 60-kD, 52-kD, and SS-B
components, respectively . The serum in lane 1 served as asource for the
purification of the affinity-purified antibodies .BEN-CHETRIT ET AL .
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to investigate the possibility that these proteins may coexist in the same subcel-
lular particle .
Immunoprecipitation was used to determine whether the two SS-A associated
antigens show any physical relationship in their native state. If the 52-kD and
60-kD antigens are tightly associated, they might be expected to coprecipitate
even when monospecific or affinity-purified antibodies were used . Fig . 4 shows
the results of an experiment in which either whole sera or affinity-purified anti-
bodies were used to probe [s5S]methionine-labeled HeLa cell extracts by immu-
noprecipitation . Affinity-purified anti-60-kD antibody precipitated a protein
migrating at 60 kD (lane 5) . Anti-52-kD antibodies precipitated a 52-kD com-
ponent and, also, a 60-kD component (lane 6) . The fact that anti-52-kD-specific
antibodies precipitated both proteins suggests that at least some 52-kD antigen
was complexed with 60 kD in the native state . In other experiments, where
increasing amounts of affinity-purified anti-60-kD antibodies were added to
[35S]methionine-labeled cells, it has been possible to show coprecipitation of a
weaker 52-kD band . The possible implications of this finding are discussed
below .
A complementary approach for examining the in vivo relationship between
the 52- and 60-kD antigens is to analyze the RNAs species associated with each
protein . For this purpose, we used different affinity-purified antibodies and sev-
eral sera possessing various combinations of anti-SS-A/Ro and anti-SS-B/La
antibodies . Fig. 5 shows that sera containing antibodies only against 52-kD pro-
tein precipitated the same spectrum of RNAs as did sera containing anti-52-kD
and 60-kD antibodies . The affinity-purified anti-60-kD and anti-SS-B antibodies
brought down the expected RNAs (lanes 9 and 10, respectively) and the affinity-
purified anti-52-kD antibodies (lane 8) brought down the same species of RNAs
as the affinity-purified anti-60-kD antibody, although the signals were weaker .
The results with the monospecific sera as well as affinity-purified antibodies con-
firmed the notion that both antibodies are capable of precipitating the same
RNA species, a fact that may suggest either that the two proteins share the same
RNA binding sites or that some of the 60- and 52-kD proteins are in association
with each other so that each of the antibody populations is capable of precipi-
tating the same spectrum of RNAs .
Using a monospecific anti-52-kD serum and affinity-purified antibodies, we
have analyzed the intracellular localization of the 52- and 60-kD proteins by
FIGURE 4 . Immunoprecipitation of [" 5S]methionine-labeled
HeLa cell extract . Lane 1 represents a normal serum control .
Lane 2 shows 48-kD protein precipitated by monospecific anti-
SS-B serum . Lane 3 represents serum that contained anti-60-
kD and anti-52-kD antibodies, while lane 4 represents mono-
specific anti-52-kD antiserum. Lanes 5 and 6 demonstrate the
immunoprecipitation by affinity-purified anti-60-kD and anti-
52-kD antibodies, respectively . Noteworthy is the fact that
affinity-purified anti-52-kD antibodies also precipitated a faint
band of 60-kD protein (long arrow points to 60-kD and short
arrow to 52-kD bands) . The bands of 80 kD and 33 kD are not
specific since they appear in the normal control . The additional
band below the 52-kD protein in lane 3 was not identified .1566
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FIGURE 5 Immunoprecipitation of
["1p]phosphate-labeled HeLa cell
extract by sera from patients with SS
and by affinity-purified antibodies .
RNA was extracted from the immu-
noprecipitate by phenol, precipi-
tated with ethanol, and analyzed on
7M urea, 8% polyacrylamide gel .
Lane 1 represents normal serum
control . Lane 2 shows reactivity of
serum containing anti-SS-A and anti-
SS-B antibodies. Lanes 3 and 4 dem-
onstrate the RNAs precipitated by
sera containing both anti-60-kD and
anti-52-kD antibodies . Lane 5
reveals reactivity of monospecific
anti-SS-B antiserum . Lanes 6 and 7
represent sera containing anti-52-
kD antibodies only . Lanes 8, 9, and
10 demonstrate the precipitation by
affinity-purified anti-52-kD, anti-
60-kD, and anti-SS-B antibodies,
respectively . The spectrum of RNAs
brought down by either whole
serum containing anti-52-kD anti-
bodies or by affinity-purified anti-
body are the same as that shown by
anti-60-kD antibodies . The designa-
tion of the Y RNAs is based on the
data of Hendrick et al . (24) . .
indirect immunofluorescence . In both HeLa and Hep-2 cells the patterns of
intracellular distribution of the 52- and 60-kD antigens were indistinguishable,
displaying the same patterns of strong punctate nuclear and slight cytoplasmic
staining (Fig . 6) .
Finally, the distribution and relative abundance of the 52-kD protein in var-
ious cell lines were examined by immunoblotting . The lymphocytic cell lines
Raji, Wil-2, and Molt-4, as well as epithelial-derived cell lines, HeLa and SAI:
1, all contain the 52-kD protein . Further, in each cell line the 52-, 60- (SS-A)
and 48-kD (SS-B) polypeptides were present in similar quantitative ratios (Fig .
7) .
Discussion
Autoantibodies to a wide variety of cellular constituents have been reported
in different rheumatic diseases . Among these are anti-SS-A/Ro and anti-SS-B/
La antibodies detected mainly in Sjogren's syndrome and SLE (1-2). The iden-
tity of these antibodies was initially based upon immunofluorescence patterns
and Ouchterlony double diffusion analysis (5-7) . Subsequently, a variety of
methods have been applied to define the molecular identity of the SS-A/Ro anti-BEN-CHETRIT ET AL.
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FIGURE 6 .
￿
Indirect immunofluorescence of prefixed HEp-2 cells . (A) Affinity-purified anti-
60-kD antibodies ; (B) the serum is monospecific for anti-52-kD antibodies . Note the similar
punctate staining patterns in both cases and the absence of localization in condensed chro-
mosomes of the mitotic cells in prophase (arrows).
gen(s) . The 60-kD protein appears to represent the major component of the SS-
A/Ro antigen system in several reports but there still is a confusing array of
other candidate proteins (Table I) . This variation in results could be due in part
to differences in experimental methods and sera used to identify the SS-A/Ro
antigens .
In this work we have used immunoblotting and immunoprecipitation to inves-1568
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FIGURE 7 . Immunoblotting analysis of extracts of different cells .
Both 60-kD and 52-kD polypeptides are present in all three cell lines
(HeLa, Raji, and SAL-1) . Other cell lines showing similar resultswere
Molt-4 and Wil-2 .
tigate the antigens recognized by 42 SS-A/Ro+ sera. We have consistently
detected a 52-kD band in >80% of SS-A/Ro precipitin-positive sera, strongly
suggesting that this protein is, with the previously described 60-kD antigen, an
additional component of the SS-A/Ro autoantigen system. This 52-kD polypep-
tide displays antigenic differences from the previously described 60-kD protein
since each can react with a unique antibody population (Fig . 1) . The possibility
that the 52-kD protein is a degradation product of the 60 kD is unlikely based
on the lack of crossreactivity between antibodies affinity purified from each pro-
tein as well as the lack of common protease-resistant fragments in the partial
proteolysis of these proteins .
While the 52-kD protein is distinct from the 60-kD antigen, several lines of
evidence suggest that in their native state they may exist as a complex or as
associated particles . In Ouchterlony analysis, antibodies against the 52-kD pro-
tein form a precipitin line indistinguishable from that of the 60-kD antigen .
Further, using immunoprecipitation, affinity-purified anti-52-kD antibodies
coprecipitate the 60-kD antigen . Moreover, the profiles of small RNAs immu-
noprecipitated by antibodies specific for either protein are indistinguishable
(Fig . 5) . In indirect immunofluorescence, both proteins share a similar intracel-
lular localization pattern (Fig . 6) . Western blotting under nonreducing condi-
tions did not show a slower migrating protein band, suggesting that the associ-
ation between the 52- and 60-kD proteins is not through disulfide bonding (data
not shown) .
For the Sm antigen-antibody system it has been shown that there exist two
forms of antigen, one that is free and another that is bound in a complex of Sm
and U1-RNP (20) . In fact, earlier immunological studies had already indicated
the existence of free Sm and of Sm bound to nuclear U1-RNP (6, 21) . Recent
studies suggest that the interaction between Sm and U1-RNP might be even
more complex, since biochemical separation methods demonstrate three to four
fractions, some of which contain Sm antigen alone and others Sm associated
with U1-RNP (22) . A similar interaction may exist for SS-B/La and SS-A/Roantigens (23-24). The data presented here suggest that some, if not most of the
52-kD protein may be complexed with the 60-kD protein. However, since large
amounts of affinity purified anti-60-kD antibodies were required to coprecipi-
tate the 52-kD protein, the data might be interpreted to reflect a situation anal-
ogous to Sm and U1-RNP, that is, that the 60-kD antigen may exist in both the
free form and as a complex with the 52-kD protein.
It is difficult to place in the proper context the relationship of the 52-kD
antigen described here with many other antigens of somewhat similar size
described by others (3, 9, 25-27). The distinguishing features in this report are
the demonstration that the 52-kD antigen contains a distinctive epitope and is a
separate protein species from the 60-kD protein and the possible physical inter-
action between the 52- and 60-kD proteins.
In summary, the work described here defines a new component of the SS-A/
Ro antigen particle as a 52-kD protein present in the sera of 80% of patients
with detectable SS-A/Ro precipitins. While the biological function of the SS-A/
Ro antigen-containing RNP particle is not precisely known, it has been proposed
that it plays a role in regulating the distribution of cytoplasmic mRNA into
translationally active or inactive forms (28). Further characterization of the
novel 52-kD protein using biochemical and molecular biological techniques is
being pursued in the hope of gaininga better understandingof the physiological
function of the SS-A/Ro antigens and the abnormal events that result in their
behavior as immunogens in autoimmune diseases.
Summary
Anti-SS-A/Ro autoantibodies are found in the sera of patients with Sjogren's
syndrome (SS) and SLE. In the course of analyzing 61 SS patients for their
autoantibody profiles, we found that 42 were positive for anti-SS-A by double
diffusion in agarose and demonstrated precipitin lines identical to that produced
by a prototype anti-SS-A serum. Further analysis of these SS-A antibody-positive
sera by Western blotting of cell extracts revealed that 21 sera reacted with two
proteins of 60 and 52 kD, 13 sera reacted with 52-kD protein, two detected only
60 kD, while six were nonreactive. Affinity-purified anti-60-kD and anti-52-kD
antibodies reacted exclusively with their corresponding antigens . Partial prote-
olysis of these proteins did not reveal common degradation fragments. Thus the
52- and 60-kD proteins were found to be antigenically and apparently structur-
ally distinct from each other. They were also distinct from 48-kD SS-B/La pro-
tein. In immunoprecipitation using labeled cell extracts, affinity-purified anti-
52-kD antibodies brought down the 52-kD protein as well as the 60-kD band.
In [32p]orthophosphate-labeled HeLa cell extract both antibodies precipitated
the same spectrum of small RNAs (hYl-5). In indirect immunofluorescence,
anti-52-kD and anti-60-kD antibodies immunolocalized in similar subcellular
structures and showed similar punctate nuclear staining patterns. Western blot
analysis revealed that both proteins were present in lymphocytic as well as epi-
thelial human cell lines tested. The data above define a new antigen of 52 kD
which is another component of the SS-A particle and is associated in complex
formation with the previously reported 60-kD protein.
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